Paolo Tarantino: Excited to present the results of 4 studies at SABCS24
Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, shared on X:
“10 days to SABCS24.
Excited to present at the conference the results of 4 studies, made possible by collaborations with brilliant Dana-Farber Cancer Institute colleagues and with multiple external partners, Reveal Genomics, Yale University, Novartis.
Come meet me at the posters on December 11th and 12th!”
Dr. Paolo Tarantino, MD, is pursuing an advanced research fellowship at Dana-Farber Cancer Institute and Harvard Medical School, concurrently working towards a PhD in clinical research at the University of Milan.
His research focuses on exploring the HER2 oncoprotein, investigating the emerging HER2-low subgroup of breast tumors, and developing novel antibody-drug conjugates targeting every subtype of breast cancer.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023